Medizinische Hochschule Hannover (MHH) - Klinik fuer Neurologie
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Petri, Susanne
COURAGE-ALS, NCT04944784 / 2020-004040-29: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Terminated
3
486
Europe, Canada, US, RoW
Reldesemtiv, Placebo
Cytokinetics
Amyotrophic Lateral Sclerosis
07/23
07/23
ATLAS, NCT04856982 / 2020-004590-51: A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Recruiting
3
150
Europe, Canada, Japan, US, RoW
Tofersen, BIIB067, QALSODY, Placebo
Biogen
Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
08/27
08/27
NCT05039099: A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Active, not recruiting
2
63
Europe, Canada, US, RoW
AP-101, Placebo
AL-S Pharma
Amyotrophic Lateral Sclerosis
12/24
10/25
NfL-ALS, NCT06201650: Neurofilament Light Chain in Amyotrophic Lateral Sclerosis

Recruiting
N/A
3000
Europe
Neurofilament light chain
Charite University, Berlin, Germany, Boris Canessa ALS Stiftung
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
12/24
12/24
LIPCAL-ALS II, NCT06280079: Ultra-high-caloric, Fatty Diet in ALS

Not yet recruiting
N/A
392
Europe
Ultra-high-caloric fatty diet, Placebo
University of Ulm
Amyotrophic Lateral Sclerosis
05/27
05/27
Fischer, Chantal
No trials found

Download Options